Serum and saliva levels of cathepsin L in patients with acute coronary syndrome

Journal of Contemporary Dental Practice

Volumn 12, Issue 2, 2011, Pages 114-119

  Mirzaii Dizgah, Iraj ^a   Riahi, Esmail ^a  

^a AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute coronary syndrome; Cathepsin L; Resting saliva; Stimulated saliva

Indexed keywords

EID: 84856096017     PISSN: None     EISSN: 15263711     Source Type: Journal    
DOI: 10.5005/jp-journals-10024-1019     Document Type: Article

References (26)

1. Tang Q, Cai J, Shen D, Bian Z, Yan L, Wang YX, et al. Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3 beta signaling. J Mol Med 2009;87:249-60.
2. Strojnik T, Kavalar R, Trinkaus M, Lah TT. Cathepsin L in glioma progression: Comparison with cathepsin B. Cancer Detect Prev 2005;29:448-55.
3. Hook V, Yasothornsrikul S, Greenbaum D, Medzihradszky KF, Troutner K, Toneff T, et al. Arg/Lys aminopeptidase: A distinct prohormone processing pathway for the biosynthesis of peptide neurotransmitters and hormones. Biol Chem 2004;385:473-80.
4. Liu J, Sukhova GK, Yang JT, Sun J, Ma L, Ren A, et al. Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis and vascular cells. Atherosclerosis 2006;184: 302-11.
5. Ravanko K, Jarvinen K, Helin J, Kalkkinen N, Holtta E. Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts. Cancer Res 2004;64:8831-38.
6. Li W, Dalen H, Eaton JW, Yuan XM. Apoptotic death of inflammatory cells in human atheroma. Arterioscler Thromb Vasc Biol 2001;21:1124-30.
7. Mattock KL, Gough PJ, Humphries J, Burnand K, Patel L, Suckling KE, et al. Legumain and cathepsin-L expression in human unstable carotid plaque. Atherosclerosis 208:83-89.
8. Kitamoto S, Sukhova GK, Sun J, Yang M, Libby P, Love V, et al. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation 2007;115:2065-75.
9. Lafarge JC, Naour N, Clement K, Guerre-Millo M. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 92:1580-86.
10. Li W, Kornmark L, Jonasson L, Forssell C, Yuan XM. Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis 2009;202:92-102.
11. Liu Y, Li X, Peng D, Tan Z, Liu H, Qing Y, et al. Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease. Am J Cardiol 2009;103: 476-81.
12. Zhang F, Zhang Y, Li PL. Dependence of cathepsin L-induced coronary endothelial dysfunction upon activation of NAD(P)H oxidase. Microvasc Res 2009;78:45-50.
13. Dong M, Wang H, Huang H. Alterations of serum cathepsins B and L in pre-eclampsia. Clin Chim Acta 2007;377:285-87.
14. Naour N, Rouault C, Fellahi S, Lavoie ME, Poitou C, Keophiphath M, et al. Cathepsins in human obesity: Changes in energy balance predominantly affect cathepsins in adipose tissue and in circulation. J Clin Endocrinol Metab 2010;95:1861-68.
15. Zografos TA, Haliassos A, Korovesis S, Giazitzoglou E, Serelis J, Katritsis DG. Serum cathepsin levels in coronary artery ectasia. Int J Cardiol 145:606-07.
16. Zhang J, Wang P, Huang YB, Li J, Zhu J, Luo X, et al. Plasma cathepsin L and its related pro/antiangiogenic factors play useful roles in predicting rich coronary collaterals in patients with coronary heart disease. J Int Med Res 38:1389-1403.
17. Yamaguchi T, Naruishi K, Arai H, Nishimura F, Takashiba S. IL-6/sIL-6R enhances cathepsin B and L production via caveolin-1-mediated JNK-AP-1 pathway in human gingival fibroblasts. J Cell Physiol 2008;217:423-32.
18. Agha-Hosseini F, Mirzaii-Dizgah I, Mirjalili N. Relationship of unstimulated whole saliva cortisol level with severity of oral dryness feeling in menopausal women. Australian Dental Journal 2011;56:171-74.
19. Mirzaii-Dizgah I, Agha-Hosseini F. Stimulated and unstimulated saliva progesterone in menopausal women with oral dryness feeling. Clin Oral Investig 2011.
20. Agha-Hosseini F, Mirzaii-Dizgah I, Mansourian A, Khayamzadeh M. Relationship of stimulated saliva 17 beta-estradiol and oral dryness feeling in menopause. Maturitas 2009;62(2):197-99.
21. Agha-Hosseini F, Mirzaii-Dizgah I, Rahimi A. Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Med Oral Patol Oral Cir Bucal 2009;4(10):e521-e24.
22. Agha-Hosseini F, Mirzaii-Dizgah I, Rahimi A, Seilanian-Toosi M. Correlation of serum and salivary CA125 levels in patients with breast cancer. J Contemp Dent Pract 2009;10(6): E001-E008.
23. Mirzaii-Dizgah I, Hejazi SF, Riahi E, Salehi MM. Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction. Clin Oral Invest 2011.
24. Mirzaii-Dizgah I, Jafari-Sabet M. Unstimulated whole saliva creatine phosphokinase in acute myocardial infarction. Oral Dis.
25. Agha-Hosseini F, Mirzaii-Dizgah I, Mansourian A, Zabihi-Akhtechi G. Serum and stimulated whole saliva parathyroid hormone in menopausal women with oral dry feeling. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107(6):806-10.
26. Agha-Hosseini F, Dizgah IM, Amirkhani S. The composition of unstimulated whole saliva of healthy dental students. J Contemp Dent Pract May 1, 2006;7(2):104-11.